至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Optimization of peptidic HIV-1 fusion inhibitor T20 by phage display.

Protein Sci. 2019-08; 
ChenGang,CookJonathan D,YeWei,LeeJeffrey E,SidhuSachd
Products/Services Used Details Operation
Peptide Synthesis … the absence of 5HB. Peptide Synthesis T20 variants identified from phage selection (Table 1) were commercially synthesized by GenScript (Piscataway, NJ). All peptides were acetylated at the N This article is protected by copyright. All rights reserved. Page 28 … Get A Quote

摘要

The HIV fusion inhibitor T20 has been approved to treat those living with HIV/AIDS, but treatment gives rise to resistant viruses. Using combinatorial phage-displayed libraries, we applied a saturation scan approach to dissect the entire T20 sequence for binding to a prefusogenic five-helix bundle (5HB) mimetic of HIV-1 gp41. Our data set compares all possible amino acid substitutions at all positions, and affords a complete view of the complex molecular interactions governing the binding of T20 to 5HB. The scan of T20 revealed that 12 of its 36 positions were conserved for 5HB binding, which cluster into three epitopes: hydrophobic epitopes at the ends and a central dyad of hydrophilic residues. The sc... More

关键词

HIV-1,antiviral therapy,fusion inhibitor,peptide engineering,phage dis